Literature DB >> 15243027

Vancomycin-induced deletion of the methicillin resistance gene mecA in Staphylococcus aureus.

Rajan P Adhikari1, Georgina C Scales, Kere Kobayashi, John M B Smith, Brigitte Berger-Bächi, Gregory M Cook.   

Abstract

OBJECTIVE: To elucidate factors that contribute to the development of vancomycin resistance in methicillin-resistant Staphylococcus aureus (MRSA).
METHODS: Forty-nine MRSA isolates were subjected to passage selection with vancomycin to isolate mutants with reduced susceptibility to vancomycin. One mutant was chosen for detailed molecular and biochemical characterization.
RESULTS: Five vancomycin-resistant mutants (vancomycin MICs, 6-12 mg/L) were obtained in vitro from five MRSA parent isolates. Upon acquisition of vancomycin resistance, all mutants showed a concomitant decrease in oxacillin resistance. In one particular MRSA strain, selection for vancomycin resistance repeatedly produced deletions and rearrangements, including loss of the mecA gene. Pleiotropic phenotypical changes, such as yellow pigment formation, loss of haemolysis, thickened cell wall, increased resistance to lysostaphin and reduced cell wall turnover were observed in this mutant.
CONCLUSION: Acquisition of vancomycin resistance in one MRSA strain triggered mecA deletion suggesting that this deletion, coupled to other rearrangements and/or mutations, may be responsible for the increased vancomycin resistance phenotype.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15243027     DOI: 10.1093/jac/dkh350

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  12 in total

1.  In vivo detection of clonally derived methicillin-resistant/methicillin-susceptible Staphylococcus aureus strains is not a rare event.

Authors:  Patrice Francois; Ilker Uckay; Anne Iten; Gesuele Renzi; Sasi Dahran; Véronique Camus; Hugo Sax; Jacques Schrenzel
Journal:  J Clin Microbiol       Date:  2008-03-19       Impact factor: 5.948

2.  Synergism between beta-lactams and glycopeptides against VanA-type methicillin-resistant Staphylococcus aureus and heterologous expression of the vanA operon.

Authors:  Bruno Périchon; Patrice Courvalin
Journal:  Antimicrob Agents Chemother       Date:  2006-09-05       Impact factor: 5.191

3.  Spontaneous deletion of the methicillin resistance determinant, mecA, partially compensates for the fitness cost associated with high-level vancomycin resistance in Staphylococcus aureus.

Authors:  Michael J Noto; Paige M Fox; Gordon L Archer
Journal:  Antimicrob Agents Chemother       Date:  2008-01-22       Impact factor: 5.191

4.  Bacteremia due to clonally derived methicillin-resistant, gentamicin-susceptible isolates and methicillin-susceptible, gentamicin-resistant isolates of Staphylococcus aureus.

Authors:  Maria Daskalaki; Joaquin R Otero; Francisca Sanz; Fernando Chaves
Journal:  J Clin Microbiol       Date:  2007-08-15       Impact factor: 5.948

5.  Analysis of cell membrane characteristics of in vitro-selected daptomycin-resistant strains of methicillin-resistant Staphylococcus aureus.

Authors:  Nagendra N Mishra; Soo-Jin Yang; Ayumi Sawa; Aileen Rubio; Cynthia C Nast; Michael R Yeaman; Arnold S Bayer
Journal:  Antimicrob Agents Chemother       Date:  2009-03-30       Impact factor: 5.191

Review 6.  Current Paradigms of Combination Therapy in Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia: Does it Work, Which Combination, and For Which Patients?

Authors:  Warren Rose; Michael Fantl; Matthew Geriak; Victor Nizet; George Sakoulas
Journal:  Clin Infect Dis       Date:  2021-12-16       Impact factor: 9.079

7.  Novel single-nucleotide variations associated with vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.

Authors:  Lee-Chung Lin; Shih-Cheng Chang; Mao-Cheng Ge; Tsui-Ping Liu; Jang-Jih Lu
Journal:  Infect Drug Resist       Date:  2018-01-18       Impact factor: 4.003

8.  The epidemiology of Staphylococcus aureus carriage in patients attending inner city sexually transmitted infections and community clinics in Calgary, Canada.

Authors:  Alejandra Ugarte Torres; Angel Chu; Ron Read; Judy MacDonald; Daniel Gregson; Thomas Louie; Johanna Delongchamp; Linda Ward; Joann McClure; Kunyan Zhang; John Conly
Journal:  PLoS One       Date:  2017-05-25       Impact factor: 3.240

9.  Draft Genomes of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Strain MM66 and MM66 Derivatives with Altered Vancomycin Resistance Levels.

Authors:  Stephanie A Matyi; Thiruvarangan Ramaraj; Anitha Sundararajan; Ingrid E Lindquist; Nicolas P Devitt; Faye D Schilkey; Reena Lamichhane-Khadka; Peter R Hoyt; Joann Mudge; John E Gustafson
Journal:  Genome Announc       Date:  2014-07-10

10.  CAMERA2 - combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trial.

Authors:  Steven Y C Tong; Jane Nelson; David L Paterson; Vance G Fowler; Benjamin P Howden; Allen C Cheng; Mark Chatfield; Jeffrey Lipman; Sebastian Van Hal; Matthew O'Sullivan; James O Robinson; Dafna Yahav; David Lye; Joshua S Davis
Journal:  Trials       Date:  2016-03-31       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.